20-44355850-T-TA
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_175914.5(HNF4A):c.47dupA(p.Tyr16fs) variant causes a frameshift, stop gained, splice region change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Genomes: not found (cov: 32)
Consequence
HNF4A
NM_175914.5 frameshift, stop_gained, splice_region
NM_175914.5 frameshift, stop_gained, splice_region
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 5.46
Genes affected
HNF4A (HGNC:5024): (hepatocyte nuclear factor 4 alpha) The protein encoded by this gene is a nuclear transcription factor which binds DNA as a homodimer. The encoded protein controls the expression of several genes, including hepatocyte nuclear factor 1 alpha, a transcription factor which regulates the expression of several hepatic genes. This gene may play a role in development of the liver, kidney, and intestines. Mutations in this gene have been associated with monogenic autosomal dominant non-insulin-dependent diabetes mellitus type I. Alternative splicing of this gene results in multiple transcript variants encoding several different isoforms. [provided by RefSeq, Apr 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant located near the start codon (<100nt), not predicted to undergo nonsense mediated mRNA decay. There are 81 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 20-44355850-T-TA is Pathogenic according to our data. Variant chr20-44355850-T-TA is described in ClinVar as [Pathogenic]. Clinvar id is 1691373.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HNF4A | NM_175914.5 | c.47dupA | p.Tyr16fs | frameshift_variant, stop_gained, splice_region_variant | 1/10 | ENST00000316673.9 | NP_787110.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HNF4A | ENST00000316673.9 | c.47dupA | p.Tyr16fs | frameshift_variant, stop_gained, splice_region_variant | 1/10 | 1 | NM_175914.5 | ENSP00000315180.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 30
GnomAD4 exome
Cov.:
30
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Hyperinsulinism due to HNF1A deficiency Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Seattle Children's Hospital Molecular Genetics Laboratory, Seattle Children's Hospital | Dec 13, 2019 | The duplication of a single nucleotide in the first exon of HNF4A introduces a premature stop codon (p.Tyr16*). This variant is predicted to result in a loss of gene function. This is a novel duplication that has not been reported in the medical literature or in clinical databases. This variant has not been observed in presumably healthy controls in the Genome Aggregation Database. While this variant appears to be novel, a different sequence change that also results in p.Tyr16* (c.48C>G), as well as other nonsense variants in HNF4A, have been described in several individuals with congenital hyperinsulinism (PMID: 20164212, PMID: 17407387, PMID: 23348805 and others). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.